93 related articles for article (PubMed ID: 24519045)
1. [Detection of fecal peroxisome proliferator-activated receptor delta and cyclooxygenase 2 mRNA in screening of colorectal cancer].
Yu H; Yang L; Yan F; Li Y; Sun X; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):26-30. PubMed ID: 24519045
[TBL] [Abstract][Full Text] [Related]
2. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
[TBL] [Abstract][Full Text] [Related]
3. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
[TBL] [Abstract][Full Text] [Related]
4. The simultaneous expression of peroxisome proliferator-activated receptor delta and cyclooxygenase-2 may enhance angiogenesis and tumor venous invasion in tissues of colorectal cancers.
Yoshinaga M; Kitamura Y; Chaen T; Yamashita S; Tsuruta S; Hisano T; Ikeda Y; Sakai H; Nakamura K; Takayanagi R; Muto Y
Dig Dis Sci; 2009 May; 54(5):1108-14. PubMed ID: 18720000
[TBL] [Abstract][Full Text] [Related]
5. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
[TBL] [Abstract][Full Text] [Related]
6. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.
Kanaoka S; Yoshida K; Miura N; Sugimura H; Kajimura M
Gastroenterology; 2004 Aug; 127(2):422-7. PubMed ID: 15300574
[TBL] [Abstract][Full Text] [Related]
7. The expression of both peroxisome proliferator-activated receptor delta and cyclooxygenase-2 in tissues is associated with poor prognosis in colorectal cancer patients.
Yoshinaga M; Taki K; Somada S; Sakiyama Y; Kubo N; Kaku T; Tsuruta S; Kusumoto T; Sakai H; Nakamura K; Takayanagi R; Muto Y
Dig Dis Sci; 2011 Apr; 56(4):1194-200. PubMed ID: 20824502
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
[TBL] [Abstract][Full Text] [Related]
9. The expression and significance of feces cyclooxygensae-2 mRNA in colorectal cancer and colorectal adenomas.
Li X; Kong L; Liao S; Lu J; Ma L; Long X
Saudi J Gastroenterol; 2017; 23(1):28-33. PubMed ID: 28139497
[TBL] [Abstract][Full Text] [Related]
10. Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.
Yang L; Zhang H; Zhou ZG; Yan H; Adell G; Sun XF
Clin Cancer Res; 2011 Jun; 17(11):3760-70. PubMed ID: 21531809
[TBL] [Abstract][Full Text] [Related]
11. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
12. [Value of fecal and blood adenomatous polyposis coli gene and K-ras gene mutation detection in colorectal neoplasm screening].
Zhan J; Li X; Yu Z; Yuan YH; Hou J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1018-21. PubMed ID: 17666342
[TBL] [Abstract][Full Text] [Related]
13. The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers.
Delage B; Rullier A; Capdepont M; Rullier E; Cassand P
Nutr J; 2007 Sep; 6():20. PubMed ID: 17767717
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
[TBL] [Abstract][Full Text] [Related]
15. A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.
Denters MJ; Deutekom M; Bossuyt PM; Fockens P; Dekker E
Eur J Cancer Prev; 2013 Jul; 22(4):299-304. PubMed ID: 23169243
[TBL] [Abstract][Full Text] [Related]
16. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator receptor (PPAR) β/δ in psoriatic patients before and after two conventional therapeutic modalities: methotrexate and PUVA.
El Eishi N; Hegazy R; Abou Zeid O; Shaker O
Eur J Dermatol; 2011; 21(5):691-5. PubMed ID: 21697059
[TBL] [Abstract][Full Text] [Related]
18. New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNA.
Koga Y; Yamazaki N; Matsumura Y
Expert Rev Mol Diagn; 2014 Jan; 14(1):107-20. PubMed ID: 24308334
[TBL] [Abstract][Full Text] [Related]
19. [Role of cyclooxygenase-2 (COX-2) and peroxisome proliferator-activated receptor (PPAR) in gastric cancer].
Chang YW; Cho HL; Jang JY; Dong SH; Kim HJ; Kim BH; Lee JI; Chang R
Korean J Gastroenterol; 2004 May; 43(5):291-8. PubMed ID: 15156115
[TBL] [Abstract][Full Text] [Related]
20. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
